Sesen Bio, Inc.
Sesen Bio, Inc. (SESN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SESN · as of Jun 9, 2026
Key Statistics
Explore Sesen Bio, Inc. Data
sesn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 62.5%
Competitors & Peers
sesn competitorsSESN
ATYR
DBTX
GRAY
KNTE
NGMStock Performance
Full HistoryAbout Sesen Bio, Inc.
Sesen Bio, Inc. is a clinical-stage biotechnology firm deeply involved in the creation, advancement, and eventual market launch of targeted fusion protein therapeutics (TFPTs). Their primary aim is to…
what is sesen bio, inc. · sesn stock overview · sesen bio, inc. company profile · who is sesen bio, inc. ceo · sesn NASDAQ · sesen bio, inc. headquarters · sesen bio, inc. business segments
About Stock Overview & Key Data
Sesen Bio, Inc. (SESN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 6, 2014. As of the latest trading session, SESN stock price is $0.63, with a market capitalization of $128.0M. The stock has returned +6.04% over the past 12 months and -1.60% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Sesen Bio, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2024, Sesen Bio, Inc. reported revenue of — and net income of -$60.5M. For detailed data — including Sesen Bio, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Sesen Bio, Inc. (SESN) stock price is $0.63. The stock is traded on NASDAQ under the ticker symbol SESN. The 52-week range is $0.36 – $0.96.